Attenuation of Autoimmune Phenomena in a Patient with Autoimmune Polyglandular Syndrome Type 1

Figure 1

Timeline of development of autoantibodies (a), autoimmune processes (b), and smooth muscle and SSA antibodies (c) with time course of known immunosuppressive therapy also shown.

(a)

(b)

(c)